|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
PACTR |
|
Last refreshed on:
|
29 April 2013 |
|
Main ID: |
PACTR201211000435126 |
|
Date of registration:
|
15/10/2012 |
|
Primary sponsor: |
|
|
Public title:
|
TaMoVaC II
|
|
Scientific title:
|
A Phase II trial to assess the safety and immunogenicity of DNA priming |
|
Date of first enrolment:
|
2012-12-03 |
|
Target sample size:
|
198 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201211000435126 |
|
Study type:
|
interventional |
|
Study design:
|
Factorial: participants randomly allocated to either no,one,some or all interventions simultaneously,
Randomised,
Stratified allocation where factors such as age, gender, centre, or previous treatment are used in the stratification (MUHAS 80, MMRP 80, CISPOC 38),
Sealed opaque envelopes.,
|
|
|
Countries of recruitment
|
|
South Africa
| | | | | | | |
|
Contacts
|
|
Name:
|
Tamer
Barakat |
|
Address:
|
70th Gomhoria St.
35516
Mansoura
Egypt |
|
Telephone:
|
0020502262222 |
|
Email:
|
drtamerbarakat@gmail.com |
|
Affiliation:
|
Fellow in Urology |
|
|
Name:
|
Eligius
Lyamuya |
|
Address:
|
Off United Nations Road
255
Dar es Salaam
United Republic of Tanzania |
|
Telephone:
|
+255 (754) 495933 |
|
Email:
|
eligius_lyamuya@yahoo.com |
|
Affiliation:
|
Chief Investigator |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Orthotopic substitution
negative ureteral safety margin
Exclusion criteria: incontinent urinary diversion
Short ureters
Technical difficulties
Age minimum:
40 Year
Age maximum:
75 Year
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
bladder cancer
|
|
Primary Outcome(s)
|
|
1- Early perioperative complications (including urinary tract infections and urinary leakage) and mortality.
|
|
hospital stay
|
|
Secondary Outcome(s)
|
|
re-admission rate
|
|
ureteral stricture
|
|
Source(s) of Monetary Support
|
|
UNC
|
|